Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
Gunjan Dagar, Ashna Gupta, Tariq Masoodi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 33
Characterization of second primary malignancies post CAR T-cell therapy: real-world insights from the two global pharmacovigilance databases of FAERS and VigiBase
Junyi Shen, Rong Hu, Anqi Lin, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102684-102684
Open Access | Times Cited: 17
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Recent advances and future perspectives in the therapeutics of prostate cancer
Ganji Lakshmi Varaprasad, Vivek Gupta, K. Satya Prasad, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
Thuỳ Anh Bùi, Haoqi Mei, Rui Sang, et al.
EBioMedicine (2024) Vol. 106, pp. 105266-105266
Open Access | Times Cited: 15
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 9
Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T
Jiajia Wang, Huiping Wang, Yangyang Ding, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access | Times Cited: 1
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Shigao Cheng, Huiyuan Wang, Xuejia Kang, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 251-251
Open Access | Times Cited: 7
Efficient combination of radiotherapy and CAR-T – A systematic review
Wojciech Szlasa, Aleksandra Sztuder, Agnieszka Kaczmar-Dybko, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116532-116532
Open Access | Times Cited: 7
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
Yuncang Yuan, Jiawei Fan, Dandan Liang, et al.
Translational Oncology (2023) Vol. 39, pp. 101803-101803
Open Access | Times Cited: 13
Therapeutic avenues for γδ T cells in cancer
Gonçalo Palrão Costa, Sofia Mensurado, Bruno Silva‐Santos
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007955-e007955
Open Access | Times Cited: 13
Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti‐tumour activity
Yao Wang, Jianhuan Li, Zhiqian Wang, et al.
Cell Proliferation (2024)
Open Access | Times Cited: 5
All-Rounder Liposomes in Cancer Immunotherapy: Strategies and Design Applications of Engineered Liposomal Nanomaterials
Gahyun Lee, Yonghyun Choi, Joohye Hong, et al.
BioChip Journal (2024) Vol. 18, Iss. 2, pp. 211-232
Closed Access | Times Cited: 4
Improving chimeric antigen receptor T-cell therapies by using artificial intelligence and internet of things technologies: A narrative review
Alberto Boretti
European Journal of Pharmacology (2024) Vol. 974, pp. 176618-176618
Closed Access | Times Cited: 4
Charting new paradigms for CAR-T cell therapy beyond current Achilles heels
Ying Li, Zhenhua Hu, Yuanyuan Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’
Baoxiang Chen, Yanrong Deng, Xianghai Ren, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 736-749
Open Access | Times Cited: 4
Green synthesis and characterization of AgNPs, liposomal loaded AgNPs and ZnPcS4 photosensitizer for enhanced photodynamic therapy effects in MCF-7 breast cancer cells
Alexander Chota, Heidi Abrahamse, Blassan P. George
Photodiagnosis and Photodynamic Therapy (2024) Vol. 48, pp. 104252-104252
Open Access | Times Cited: 4
Unveiling the orchestration of T-cell dynamics: A comprehensive examination of their crucial role in revolutionizing immunotherapy for pancreatic and colon cancers
Sridevi Mardham, Soumya Dakshinamurthy
Elsevier eBooks (2025), pp. 199-232
Closed Access
Role of T-cells in immunotherapy of pancreatic and colon cancers
Ashni Dudhia, Mia Rajan, Keshav Patel, et al.
Elsevier eBooks (2025), pp. 233-244
Closed Access
Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
Alejandrina Hernández-López, Alberto Olaya‐Vargas, Juan Carlos Bustamante Ogando, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 156-156
Open Access
Multiple myeloma and anti-BCMA CAR-T therapy: a literature review
A. P. Faenko, Г. А. Дудина, C. K. Mabudzade
MD-Onco (2025) Vol. 4, Iss. 4, pp. 53-64
Closed Access
Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers.
Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, et al.
European Journal of Pharmacology (2025), pp. 177309-177309
Closed Access
Page 1 - Next Page

Scroll to top